BE546061A - - Google Patents
Info
- Publication number
- BE546061A BE546061A BE546061DA BE546061A BE 546061 A BE546061 A BE 546061A BE 546061D A BE546061D A BE 546061DA BE 546061 A BE546061 A BE 546061A
- Authority
- BE
- Belgium
- Prior art keywords
- poliomyelitis
- virus
- live
- viruses
- aqueous medium
- Prior art date
Links
- 241000700605 Viruses Species 0.000 claims description 126
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 116
- 208000000474 Poliomyelitis Diseases 0.000 claims description 84
- 229960005486 vaccine Drugs 0.000 claims description 59
- 239000012736 aqueous medium Substances 0.000 claims description 50
- 208000015181 infectious disease Diseases 0.000 claims description 47
- 238000000034 method Methods 0.000 claims description 47
- 239000002609 medium Substances 0.000 claims description 36
- 241000991587 Enterovirus C Species 0.000 claims description 32
- 238000011282 treatment Methods 0.000 claims description 27
- 230000002458 infectious effect Effects 0.000 claims description 26
- 241000124008 Mammalia Species 0.000 claims description 20
- 230000008569 process Effects 0.000 claims description 20
- 238000011534 incubation Methods 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 8
- 230000036039 immunity Effects 0.000 claims description 7
- 230000001580 bacterial effect Effects 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 229960001950 benzethonium chloride Drugs 0.000 claims description 5
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 claims description 5
- 230000003053 immunization Effects 0.000 claims description 5
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims description 3
- 239000003381 stabilizer Substances 0.000 claims description 2
- 239000010409 thin film Substances 0.000 claims description 2
- 229940124867 Poliovirus vaccine Drugs 0.000 claims 5
- 235000012544 Viola sororia Nutrition 0.000 claims 1
- 241001106476 Violaceae Species 0.000 claims 1
- 229960004279 formaldehyde Drugs 0.000 description 29
- 235000019256 formaldehyde Nutrition 0.000 description 27
- 230000000890 antigenic effect Effects 0.000 description 16
- 241000282693 Cercopithecidae Species 0.000 description 15
- 239000000047 product Substances 0.000 description 14
- 239000007788 liquid Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 239000000523 sample Substances 0.000 description 9
- 238000010438 heat treatment Methods 0.000 description 8
- 238000011076 safety test Methods 0.000 description 8
- 239000000725 suspension Substances 0.000 description 7
- 239000011521 glass Substances 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 230000005855 radiation Effects 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 239000007858 starting material Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 229960001539 poliomyelitis vaccine Drugs 0.000 description 3
- 210000005084 renal tissue Anatomy 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- 239000012981 Hank's balanced salt solution Substances 0.000 description 2
- 241000282560 Macaca mulatta Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 229940037003 alum Drugs 0.000 description 2
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 2
- 230000000721 bacterilogical effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000001066 destructive effect Effects 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000003104 tissue culture media Substances 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 210000001985 kidney epithelial cell Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000003303 reheating Methods 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000009781 safety test method Methods 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000010972 statistical evaluation Methods 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 239000013026 undiluted sample Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE546061A true BE546061A (Sortimente) |
Family
ID=173495
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE546061D BE546061A (Sortimente) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE546061A (Sortimente) |
-
0
- BE BE546061D patent/BE546061A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3019168A (en) | Heat and ultra-violet light attenuation of polio virus | |
| FR2472386A1 (Sortimente) | ||
| FR2723740A1 (fr) | Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications | |
| CH668960A5 (fr) | Milieu, dispositif et procede pour separation cellulaire. | |
| BE546061A (Sortimente) | ||
| US20120136338A1 (en) | Immunologic compounds for prevention, protection, prophylaxis or treatment of immunological disorders, infections and cancer | |
| Jörgensen | Micro-organisms and Fermentation | |
| CN105073131B (zh) | 用于释放病毒样颗粒的方法 | |
| BE1023903B1 (fr) | Nouveau procédé | |
| CN118879557A (zh) | 一种副猪嗜血杆菌5型gd1022株外膜囊泡及其制备方法与应用 | |
| EP4263801A1 (fr) | Milieu de culture, procede de fabrication et procede de culture bacterienne | |
| FR2695140A1 (fr) | Procédé d'inactivation virale des produits plasmatiques par des fluides supercritiques ou subcritiques. | |
| CH363441A (fr) | Procédé de préparation d'un vaccin antipoliomyélitique | |
| CH361360A (fr) | Procédé de préparation d'un vaccin antipoliomyélitique | |
| EP2167651B1 (fr) | Procede de purification d'une suspension virale | |
| BE557398A (Sortimente) | ||
| CN114949198A (zh) | 一种禽类动物疫苗用油包水佐剂及其制备方法和应用 | |
| NO120204B (Sortimente) | ||
| EP0051522A1 (fr) | Mutant de septicémie hémorragique virale, vaccin contenant ce mutant et procédé pour sa préparation | |
| EP1819369A1 (fr) | Inactivation d'agents biologiques disperses en milieu gazeux par un semi-conducteur photoactive | |
| CN118813478A (zh) | 一种副猪嗜血杆菌外膜囊泡及其疫苗、制备方法与应用 | |
| FR2646778A1 (fr) | Suspensions de cellules memoire immunitaires et leur procede de preparation | |
| BE560604A (Sortimente) | ||
| EP1092471A1 (fr) | Adjuvant de filtration de liquides et son utilisation pour la décontamination microbienne | |
| CN118956668A (zh) | 一种副猪嗜血杆菌4型sh1012株外膜囊泡及其制备方法与应用 |